SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-049880
Filing Date
2021-10-04
Accepted
2021-10-04 07:03:30
Documents
14
Period of Report
2021-10-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xene-8k_20211004.htm   iXBRL 8-K 37774
2 EX-99.1 xene-ex991_6.htm EX-99.1 48081
3 GRAPHIC g1ex51tngowu000001.jpg GRAPHIC 7563
  Complete submission text file 0001564590-21-049880.txt   234432

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA xene-20211004.xsd EX-101.SCH 5701
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE xene-20211004_lab.xml EX-101.LAB 19292
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xene-20211004_pre.xml EX-101.PRE 11485
7 EXTRACTED XBRL INSTANCE DOCUMENT xene-8k_20211004_htm.xml XML 3530
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36687 | Film No.: 211300983
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences